Inventor · disambiguated record
Jackaline D. Julien
Also filed as: JULIEN JACKALINE D · JULIEN JACKALINE DALGARD
12 granted patents·193 citations·filing 2010–2016
91Inventor score
Technology areasA61P
Files withSMITH NICHOLAS D4SERAGON PHARMACEUTICALS INC3ARAGON PHARMACEUTICALS INC2BOLLU VENKATAIAH2GENENTECH INC1
Top patents by PatentIndex Score
12 records- 0197US8455534B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2012·Granted Jun 4, 2013·66 cites·18 claims
- 0297US8299112B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Oct 30, 2012·72 cites·12 claims
- 0390US9108944B2Androgen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Aug 18, 2015·16 cites·38 claims
- 0489US9481664B2Androgen receptor modulators and uses thereofARAGON PHARMACEUTICALS INC·Filed 2015·Granted Nov 1, 2016·8 cites·42 claims
- 0588US9187460B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·11 cites·17 claims
- 0683US9586952B2Polycyclic estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2014·Granted Mar 7, 2017·7 cites·37 claims
- 0783US9399646B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Jul 26, 2016·6 cites·15 claims
- 0878US9499538B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2013·Granted Nov 22, 2016·4 cites·13 claims
- 0969US8785488B2Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesityBOLLU VENKATAIAH·Filed 2010·Granted Jul 22, 2014·3 cites·14 claims
- 1060US9868704B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Jan 16, 2018·0 cites·18 claims
- 1155US10023556B2Androgen receptor modulators and uses thereofARAGON PHARMACEUTICALS INC·Filed 2016·Granted Jul 17, 2018·0 cites·19 claims
- 1231US8846739B2TGR5 agonistsBOLLU VENKATAIAH·Filed 2010·Granted Sep 30, 2014·0 cites·23 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →